Joseph Podojil

Director, Immunology COUR Pharmaceuticals

Seminars

Thursday 26th March 2026
Advancing Non-Cell Therapy Innovations to Combat Autoimmune & Inflammatory Diseases
2:30 pm
  • Highlighting apoptosis driven immune tolerance key signaling pathways
  • Discussing supporting preclinical and mechanistic studies that inform trial design
  • Reviewing clinical trial data in celiac disease and primary biliary cholangit
Joe Podojil